BioCentury
ARTICLE | Clinical News

Cotinine fumarate data

October 30, 1995 8:00 AM UTC

LECT presented Phase II data, using 100 mg of the drug, at the meeting of the American Society of Addiction Medicine conference on nicotine dependence in Toronto. The data showed an increase in the rate of continuous abstinence in heavy smokers, with relief of several symptoms of tobacco withdrawal.

Cotinine, a byproduct of nicotine metabolism, contributes to the pharmacologic effect of nicotine. ...